Skip to main content
OpenTrials

Clinical trial condition

Anatomic Stage II Breast Cancer AJCC v8

Explore clinical trials studying Anatomic Stage II Breast Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

107 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Anatomic Stage II Breast Cancer AJCC v8 trial results

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

NCT06058377

Conditions
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, +1 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 544 locations
View Trial Details
Recruiting

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

NCT06113016

Conditions
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +1 more
Locations
  • UCLA Health Cancer Care in Alhambra Alhambra, California, United States
  • UCLA Health Beverly Hills Primary & Specialty Care Beverly Hills, California, United States
  • UCLA Health Burbank Primary & Specialty Care Burbank, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details
Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

NCT07391774

Conditions
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, +2 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation Health Care Palo Alto, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
View all 72 locations
View Trial Details
Recruiting

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

NCT05595499

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Locations
  • UCLA Health Cancer Care in Alhambra Alhambra, California, United States
  • UCLA Health Beverly Hills Primary & Specialty Care Beverly Hills, California, United States
  • UCLA Health Burbank Primary & Specialty Care Burbank, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View Trial Details
Recruiting

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

NCT05464810

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +3 more
Locations
  • Grady Healthcare System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Recruiting

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

NCT05812807

Conditions
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, +1 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 842 locations
View Trial Details
Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

NCT06876714

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2+ Breast Cancer
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 671 locations
View Trial Details

Related conditions